Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer
Kaoru Nishikawa(University of Shizuoka), Tetsuo Minamino(Kagawa University), Eisuke Mekada(Osaka University), Yoshihiro Asano(National Cerebral and Cardiovascular Center), Hisakazu Kato(The University of Osaka), Kosuke Shimizu(Hamamatsu Photonics (Japan)), Tomohiro Asai(University of Shizuoka), Naoto Oku(University of Shizuoka), Hirokazu Shigematsu(Dana-Farber Cancer Institute), Seiji Takashima(Kindai University)
Cited by 56
Related Papers
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
|Cancer Cell|2004|701
Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticles: A Plastic Antibody
|Journal of the American Chemical Society|2010|486
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
|Blood|2005|456
Tyrosine Phosphorylation of β-Catenin and Plakoglobin Enhanced by Hepatocyte Growth Factor and Epidermal Growth Factor in Human Carcinoma Cells
|Cell Communication & Adhesion|1994|417
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288